← Eichor
Study identifier: NCT07247344 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study

Condition: Adolescent · Major Depressive Disorder (MDD · Bipolar Disorder (BD)  ·  Sponsor: Jiangsu Province Nanjing Brain Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 10 Years to 20 Years
Healthy volunteersNo

About this study

This cohort study involves the dynamic collection of clinical information from adolescent patients with major depressive episodes (including both major depressive disorder and bipolar disorder), encompassing serum parameters, physiological-behavioral signals, neuroimaging data, and neuropsychological scales. The study aims to summarize the comprehensive clinical characteristics of this population, identify new risk factors, and establish multivariate predictive models for treatment response, cognitive and emotional impairments. Furthermore, this research will thoroughly investigate the underlying neural mechanisms linking clinical manifestations and neuroimaging features in major depressive episodes.

This description comes directly from the study's public registry record.

Talk to the study team

Zexin Lin  ·  86-13906900678  ·  zexinlin@stu.njmu.edu.cn

Jia Duan  ·  86-025-83295957  ·  jia_duan@yeah.net

Always discuss trial participation with your own doctor first.

Locations (1)

210000Nanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07247344